Save your place

Sign in to WhoBought

Please try again later.

Globus Medical, Inc. (GMED) institutional ownership

Latest close $78.25 Jul 27, 2026
Market cap$12.1B 52-week range SectorHealthcare
Funds holding · Q1 2026
557
reported GMED position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $136M
327 buyers · 230 sellers

Globus Medical, Inc. (GMED) price and institutional activity

Dates

Q1 2026

$1.1B bought by 327 investors
Millennium Management LLC$127MHolocene Advisors, LP$69M +325 more
$1.2B sold by 230 investors
Madison Avenue Partners, LP-$171MBank of Montreal-$96M +228 more
Bought Sold Totals per quarter; hover a bar for the names.

Globus Medical, Inc. (GMED) institutional activity · 557

Investor Type Est. change Change Δ Own Date
Madison Avenue Partners, LP · Reduced −$171M
Change −1.9M Date Q1 2026
Madison Avenue Partners, LP Reduced· Q1 2026 −$171M −1.9M Q1 2026
Millennium Management LLC · Added +$127M
Change +1.4M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +$127M +1.4M Q1 2026
Bank of Montreal · Reduced −$96M
Change −1.1M Date Q1 2026
Bank of Montreal Reduced· Q1 2026 −$96M −1.1M Q1 2026
Norges · Exited −$92M
Change −1.0M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$92M −1.0M −100.0% Q1 2026
Parsifal Capital Management, LP · Reduced −$75M
Change −836K Date Q1 2026
Parsifal Capital Management, LP Reduced· Q1 2026 −$75M −836K Q1 2026
Walleye Capital LLC · Reduced −$74M
Change −819K Date Q1 2026
Walleye Capital LLC Reduced· Q1 2026 −$74M −819K Q1 2026
Holocene Advisors, LP · New +$69M
Change +774K Date Q1 2026
Holocene Advisors, LP New· Q1 2026 +$69M +774K Q1 2026
AQR Capital Management LLC · Added +$65M
Change +729K Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +$65M +729K Q1 2026
Vestal Point Capital, LP · Reduced −$60M
Change −664K Date Q1 2026
Vestal Point Capital, LP Reduced· Q1 2026 −$60M −664K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −$51M −573K −22.6% Q1 2026
FMR LLC · Added +$49M
Change +551K Δ Own +1121.3% Date Q1 2026
FMR LLC Added· Q1 2026 +$49M +551K +1121.3% Q1 2026
William Blair Investment Management, LLC · Reduced −$46M
Change −510K Date Q1 2026
William Blair Investment Management, LLC Reduced· Q1 2026 −$46M −510K Q1 2026
JPMorgan Chase & Co · Reduced −$45M
Change −503K Date Q1 2026
JPMorgan Chase & Co Reduced· Q1 2026 −$45M −503K Q1 2026
Hawk Ridge Capital Management LP · New +$45M
Change +500K Date Q1 2026
Hawk Ridge Capital Management LP New· Q1 2026 +$45M +500K Q1 2026
Arrowstreet Capital, Limited Partnership · Added +$42M
Change +472K Date Q1 2026
Arrowstreet Capital, Limited Partnership Added· Q1 2026 +$42M +472K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 557

Famous investor activity in Globus Medical, Inc. (GMED)

Globus Medical, Inc. (GMED) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Davidar David D. · Director Gift (G) -2K
Owned 508K ΔOwn −0.5% Trade date Jul 27, 2026 Filed date Jul 28, 2026
Davidar David D. Director Gift (G) -2K 508K −0.5% Jul 27, 2026 Jul 28, 2026
Davidar David D. · Director Sell −$2.0M
Price $80.76 Qty −25K Owned 510K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Davidar David D. Director Sell $80.76 −25K −$2.0M 510K Jun 5, 2026 Jun 9, 2026
Davidar David D. · Director 2 operations 0
Price $26.27 Owned 0 Trade date Jun 5, 2026 Filed date Jun 9, 2026
Davidar David D. Director 2 operations $26.27 0 0 Jun 5, 2026 Jun 9, 2026
Rhoads Ann D. · Director 2 operations 0
Price $26.27 Owned 0 Trade date Jun 4, 2026 Filed date Jun 8, 2026
Rhoads Ann D. Director 2 operations $26.27 0 0 Jun 4, 2026 Jun 8, 2026
Huller Kelly · Officer Sell −$1.9M
Price $94.50 Qty −20K Owned 0 Trade date Feb 25, 2026 Filed date Feb 27, 2026
Huller Kelly Officer Sell $94.50 −20K −$1.9M 0 Feb 25, 2026 Feb 27, 2026
Huller Kelly · Officer 2 operations 0
Price $43.58 Owned 20K Trade date Feb 25, 2026 Filed date Feb 27, 2026
Huller Kelly Officer 2 operations $43.58 0 20K Feb 25, 2026 Feb 27, 2026
Huller Kelly · Officer Sell −$877K
Price $87.67 Qty −10K Owned 0 Trade date Feb 12, 2026 Filed date Feb 17, 2026
Huller Kelly Officer Sell $87.67 −10K −$877K 0 Feb 12, 2026 Feb 17, 2026
Huller Kelly · Officer 2 operations 0
Price $45.64 Owned 0 Trade date Feb 12, 2026 Filed date Feb 17, 2026
Huller Kelly Officer 2 operations $45.64 0 0 Feb 12, 2026 Feb 17, 2026
Norwalk Leslie V · Director Grant (A) 15K
Owned 15K Trade date Jan 21, 2026 Filed date Jan 23, 2026
Norwalk Leslie V Director Grant (A) 15K 15K Jan 21, 2026 Jan 23, 2026
Pfeil Keith W. · Director, Officer Grant (A) 100K
Owned 100K Trade date Jan 21, 2026 Filed date Jan 23, 2026
Pfeil Keith W. Director, Officer Grant (A) 100K 100K Jan 21, 2026 Jan 23, 2026
Kline Kyle · Officer Grant (A) 30K
Owned 30K Trade date Jan 21, 2026 Filed date Jan 23, 2026
Kline Kyle Officer Grant (A) 30K 30K Jan 21, 2026 Jan 23, 2026
Paul David C. · Director, Officer, 10% Owner Grant (A) 100K
Owned 100K Trade date Jan 21, 2026 Filed date Jan 23, 2026
Paul David C. Director, Officer, 10% Owner Grant (A) 100K 100K Jan 21, 2026 Jan 23, 2026
Douglas Robert Andrew · Director Grant (A) 15K
Owned 15K Trade date Jan 21, 2026 Filed date Jan 23, 2026
Douglas Robert Andrew Director Grant (A) 15K 15K Jan 21, 2026 Jan 23, 2026
Lemaitre Dan · Director Grant (A) 15K
Owned 15K Trade date Jan 21, 2026 Filed date Jan 23, 2026
Lemaitre Dan Director Grant (A) 15K 15K Jan 21, 2026 Jan 23, 2026
Rhoads Ann D. · Director Grant (A) 15K
Owned 15K Trade date Jan 21, 2026 Filed date Jan 23, 2026
Rhoads Ann D. Director Grant (A) 15K 15K Jan 21, 2026 Jan 23, 2026
15 of 37
15 of 37 Sign in to continue to older insider transactions.

Globus Medical, Inc. (GMED) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Capital Management 5.9M
% of shares outstanding 5.2% Filing date Apr 30, 2026
Vanguard Capital Management 5.9M 5.2% Apr 30, 2026
1 of 1

Globus Medical, Inc. (GMED) ownership FAQ

Who owns GMED?

557 reporting institutions disclosed GMED position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.